Breaking News, Trials & Filings

Trials & Filings in Brief: Sept. 26, 2013

Dompe, Exelixis, Lilly, Lumena, NovaRx, ProMetic, Sarepta,

Preclinical
ProMetic’s fibrosis candidate safe for trials . . . read more

Phase II
Positive results for Sarepta in DMD extension . . . read more

Lumena tests LUM001 in rare liver disease in children . . . read more

Phase II/III
Dompe to test Reparixin in autologous islet cell transplantation . . . read more

Phase III
Mixed results for Lilly . . . read more

Lucanix results miss endpoint in NSCLC . . . read more

Exelixis completes enrollment in mCRPC trial . . . read more

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters